510(k) Report

510(k) · Cleared

Cleared

iTind System

K210138510(k) TraditionalCleared Jun 25, 2021157-day reviewClass II21 CFR 876.5510

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Medi-Tate, Ltd. · QKA Temporarily-Placed Urethral Opening System For Symptoms Of Benign Prostatic Hyperplasia

Cleared on Jun 25, 2021 as substantially equivalent to DEN190020 (Medi-Tate, Ltd., 2020) after a 157-day review. Its family tree reaches back 1 generation to 2020.

Decided
Jun 25, 2021
Review
157 days
Class
Class II
Product code
QKA
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to DEN190020 (2020). No later device cites it as a predicate yet.

DEN190020 · iTind System · Medi-Tate, Ltd. · 202020202022
DEN190020 · iTind System · Medi-Tate, Ltd. · 20200
  1. Root · 1 generation backDEN190020 iTind SystemMedi-Tate, Ltd. · 2020
  2. This deviceK210138 iTind SystemMedi-Tate, Ltd. · 2021
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1DEN190020iTind SystemMedi-Tate, Ltd.2020—
0 (this device)K210138iTind SystemMedi-Tate, Ltd.2021—
FIG. 1 — Lineage of K210138, 2020–2021Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in QKA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new QKA device

  1. #1 K253525 Urocross Expander System (Model Numbers ES2018…score 14.0 · 1 generation · no Class I recall
  2. #2 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*DEN190020iTind System
Summary page 4
…ystem for Symptoms of Benign Prostatic Hyperplasia Regulation Number: 21 CFR 876.5510 Regulatory Class: II Product Code: QKA Predicate Device: DEN190020 – Medi-Tate’s iTind Device Description The iTind System is a prescription temporary implantable transprostatic tissue re…
Medi-Tate, Ltd.2020—

Also cleared against DEN190020: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • 1 other device also cites its predicate DEN190020.

How does its category compare?

All QKA devices

QKA Temporarily-Placed Urethral Opening System For Symptoms Of Benign Prostatic Hyperplasia: FDA decisions, review times, recalls and adverse event reports over 20 years. 2021, this device’s year, is highlighted.

FDA decisions per year · QKA

2so far in 2026, the most since 2007

2020: 12021: 12026 (partial year): 2
2007high 2 (2026) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QKA

Too few QKA 510(k)s in any year since 2007 to give a median.

Recalls per year · QKA

No recall names QKA since 2007.

Adverse event reports per year · QKA

5in 2025

2021: 12024: 52025: 5
2007high 5 (2024) · low 0 (2007)2025

MAUDE reports naming product code QKA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20201—00
20211—01
20220—00
20230—00
20240—05
20250—05
20262—0—

What is it indicated for?

The iTind System is intended for the treatment of symptoms due to urinary outflow obstruction secondary to benign prostatic hyperplasia (BPH) in men age 50 and above.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K210138: iTind System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K210138

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026